Inspiring Scientific Discovery
Search hundreds of thousands of products backed by our one-year, replacement or money-back, satisfaction guarantee.
Bioss COVID-19 Products
The ultimate goal of Bioss is to improve the health and quality of life of humans and animals. To fight against COVID-19, Bioss has developed antibodies, proteins, and the ELISA kit in support of studies on the novel coronavirus.
Quality Antibody Promotion
In honor of scientists who are doing fantastic research, we are presenting a collection of 45 popular featured Quality Antibodies with a 25% discount.
Haven't worked with Bioss Antibodies before? Try one of our 20uL trial-sized vials for just $0.01 plus shipping. Click here to view program details and to request your discount code for this promotional pricing.
Antibody neutralization assays help assess the protective effect of COVID-19 vaccines.
- Biomarkers in Alzheimer’s DiseaseBiomarkers offer valuable tools to measure and track different disease mechanisms, cellular alterations, and disturbances in pathways “in vivo” and pave the way for discovering novel drug targets.
- SARS-CoV-2 Variants and the Diagnostic ImmunoassayThe recent emergence of SARS-CoV-2 variants has prompted concerns as to their susceptibility to vaccine neutralization. Meanwhile, another concern on whether such strains may evade detection by diagnostics draws equal attention because this possibility will dampen our accuracy of disease tracking.
- Immune Escape and Spike RBD MutationsThe mutation is a common phenomenon in the natural evolution of viruses, and SARS-CoV-2 is no exception. Although SARS-CoV-2 has low genomic variability because of its proofreading function, the emergence of a variety of SARS-CoV-2 mutants during the ongoing pandemic showed more transmittable and might be able to evade neutralizing antibodies induced by either infection or vaccination, so-called immune escape.
Bioss Pathway Maps
Diving into a new project? Get up to speed quickly with these cellular and molecular pathway maps. Each one is expertly researched and hand-drawn by our scientific team. Autophagy, Tumor Immunology, MAPK, WNT Signaling, and many others are available to download, print, and share at your convenience.
Bioss Inc is a leading antibody developer and manufacturer with state of the art technologies. We have developed over 11,000 primary antibodies and more than 130,000 derived products including fluorochrome conjugated antibodies. In addition to reliable loading control and tag antibodies, our catalog includes over 1000 specific antibodies recognizing proteins with phosphorylation, acetylation, or methylation modifications.